Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival
Open Access
- 3 March 2012
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 31 (1) , 18
Abstract
Background: Sex determining region Y (SRY)-related high mobility groupbox 9 (SOX9) is an important transcription factor required for development, which regulates the expression of target genes in the associated pathway. The aim of this study was to describe the expression of SOX9 in human non-small cell lung cancer (NSCLC) and to investigate the association between SOX9 expression and progression of NSCLC. Methods: SOX9 protein and mRNA expression in normal human pneumonocytes, lung cancer cell lines, and eight pairs of matched lung cancer tissues and their adjacent normal lung tissues were detected by Western blotting and real-time reverse transcription-polymerase chain reaction (RT-PCR). Immunohistochemistry was used to determine SOX9 protein expression in 142 cases of histologically characterized NSCLC. Statistical analyses were applied to test for prognostic and diagnostic associations. Results: SOX9 in lung cancer cell lines was upregulated at both mRNA and protein levels, and SOX9 mRNA and protein were also elevated in NSCLC tissues compared with levels in corresponding adjacent non-cancerous lung tissues. Immunohistochemical analysis demonstrated a high expression of SOX9 in 74/142 (52.1%) paraffin-embedded archival lung cancer biopsies. Statistical analysis indicated that upregulation of SOX9 was significantly correlated with the histological stage of NSCLC (P = 0.017) and that patients with a high SOX9 level exhibited a shorter survival time (P < 0.001). Multivariate analysis illustrated that SOX9 upregulation might be an independent prognostic indicator for the survival of patients with NSCLC. Conclusions: This work shows that SOX9 may serve as a novel and prognostic marker for NSCLC, and play a role during the development and progression of the disease.Keywords
This publication has 17 references indexed in Scilit:
- Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and TumorigenicityClinical Cancer Research, 2010
- Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-κB PathwayThe American Journal of Pathology, 2010
- SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cellsBreast Cancer Research and Treatment, 2009
- Analysis of SOX9 Expression in Colorectal CancerAmerican Journal of Clinical Pathology, 2008
- Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient SurvivalClinical Cancer Research, 2008
- SOX9 Is Expressed in Human Fetal Prostate Epithelium and Enhances Prostate Cancer InvasionCancer Research, 2008
- The Molecular Action and Regulation of the Testis-Determining Factors, SRY (Sex-Determining Region on the Y Chromosome) and SOX9 [SRY-Related High-Mobility Group (HMG) Box 9]Endocrine Reviews, 2003
- Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related geneNature, 1994
- Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9Cell, 1994
- Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus.1993